Valeant nears deal to buy Salix for about $10 billion: WSJ

samedi 21 février 2015

The head offices of Valeant Pharmaceuticals International Inc. are seen in Laval, Quebec Valeant Pharmaceuticals International is near a deal to buy Salix Pharmaceuticals Ltd for about $10 billion, the Wall Street Journal reported on Saturday.








via Business News http://ift.tt/1B1CwzH

0 commentaires:

Enregistrer un commentaire